The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020

Background: In recent years, new drug development on lung cancer is in full swing in China. The aim of this study was to overview the changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020. Methods: We analysed anti-lung cancer drug clinical trials registered...

Full description

Bibliographic Details
Main Authors: Qiaofeng Zhong, Yunxia Tao, Haizhu Chen, Yu Zhou, Liling Huang, Xiaohong Han, Yuankai Shi
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606521000602